A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to examine if a combination of a cholesterol
lowering-drug, simvastatin, with a sugar-lowering drug called rosiglitazone is more effective
in improving vascular inflammation (irritation of the vessels that transport your blood) and
other cardiovascular risk factors than the taking of simvastatin alone.